Low-voltage-activated (T-type) calcium channels control proliferation of human pulmonary artery myocytes

David M Rodman1, Katherine Reese, Julie Harral

  • 1Center for Genetic Lung Disease, University of Colorado Health Sciences Center, Denver, Colo 80262, USA. david.rodman@uchsc.edu

Circulation Research
|March 19, 2005
PubMed

Insights

T-type calcium channels, specifically Ca(v)3.1, are crucial for human pulmonary artery smooth muscle cell proliferation and cell cycle progression. Blocking these channels inhibits cell growth, highlighting their essential role.

Area of Science:

  • Cell Biology
  • Physiology
  • Molecular Biology

Background:

  • Calcium ion (Ca2+) influx regulates cell cycle machinery, but its precise control mechanisms remain unclear.
  • Multiple Ca2+ channel genes exist in mammalian cells, including the Ca(v)3.x family encoding low voltage-activated (LVA) or T-type channels.
  • The role of T-type Ca2+ channels in cell proliferation is debated, with conflicting reports in existing literature.

Purpose of the Study:

  • To investigate the role of T-type Ca2+ channels (Ca(v)3.x genes) in regulating the proliferation and cell cycle progression of human pulmonary artery smooth muscle cells (PA SMCs).

Main Methods:

  • Quantitative RT/PCR to determine Ca(v)3.x gene expression.
  • Immunocytochemistry and immunohistochemistry to localize Ca(v)3.1 channels.
  • Selective blockade of Ca(v)3.1 using small interfering RNA (siRNA).
  • Pharmacological blockade of T-type channels.

Main Results:

  • Ca(v)3.1 was identified as the predominant Ca(v)3.x channel in human PA SMCs in vitro and in pulmonary arteries in vivo.
  • Inhibition of Ca(v)3.1 expression or T-type channel activity completely blocked serum-induced proliferation.
  • Cell cycle entry was prevented upon blockade of T-type Ca2+ channels.

Conclusions:

  • T-type voltage-operated Ca2+ channels are essential for the proliferation and cell cycle progression of human PA SMCs.
  • Ca(v)3.1 channels play a critical role in regulating these cellular processes in the pulmonary artery media.
  • Targeting T-type channels may offer a therapeutic strategy for conditions involving PA SMC hyperproliferation.

Related Concept Videos

Feedback Regulation of Calcium Concentration01:27

Feedback Regulation of Calcium Concentration

Calcium is an essential signaling molecule required for various cellular functions. Calcium pumps and ion channels on cell and organellar membranes, such as those on the endoplasmic reticulum (ER), regulate calcium concentrations inside the cell. They remain closed, keeping the cytosolic calcium levels low at a resting state.
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Smooth Muscle Contraction01:25

Smooth Muscle Contraction

Smooth muscle contraction is a complex process vital for various bodily functions, from maintaining blood vessel tension to facilitating the movement of food through the digestive tract. Unlike striated muscles, smooth muscle contraction begins more slowly and lasts longer.
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...